Westerkirk Capital »

AstraZeneca shares owned by Westerkirk Capital

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Westerkirk Capital from 13F filings

Historical chart of Westerkirk Capital investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Westerkirk Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Westerkirk Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $906k 12k 76.72

More positions owned by Westerkirk Capital

Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Mastercard Incorporated Cl A (MA)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
TJX Companies (TJX)
Canadian Pacific Kansas City (CP)

View all positions for Westerkirk Capital

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
Capital Research and Management Company - Division 3
FMR
Fisher Investments
Franklin Resources
Sanders Capital
Goldman Sachs Group
Morgan Stanley
Atlantic Trust
Dimensional Fund Advisors
Holocene Advisors
BlackRock
Ameriprise Financial
Robeco Investment Management

View all funds holding AstraZeneca